XiFin Inc. Successfully Completes SAS 70 Type II Audit
February 17, 2009XiFin, Inc., the leading provider of revenue cycle management solutions for diagnostic laboratories, announced today that it has successfully completed a SAS 70 (Statement on Auditing Standards No. 70) Type II audit.
Statement on Auditing Standards (SAS) No. 70 is an internationally recognized auditing standard developed by the American Institute of Certified Public Accountants (AICPA). A SAS 70 audit is widely respected because it demonstrates that a service organization has been through an in-depth audit of their control activities, which generally includes controls over information technology and related processes. Federal regulations such as Sarbanes-Oxley, Gramm-Leach-Bliley and the Health Insurance Portability and Accountability Act (HIPAA) require corporations to audit the internal controls of their suppliers, including those that provide on-demand services. XiFin’s SAS 70 Type II audit was performed by independent auditor, SAS70 Solutions, Certified Public Accountants, who has verified and validated that the organization is actively following these procedures, policies, and controls.
“This certification demonstrates our commitment to deliver on our goal of being the partner of choice for Revenue Cycle Management solutions,” said Lale White, XiFin’s CEO and Executive Chairman. “It’s just one of the many ways we provide accountability to our clients and assure them that the data they entrust us with are safeguarded.”
About XiFin
XiFin is an innovative software and services company dedicated to optimizing the economics of healthcare. The company’s cloud-based technology and business intelligence platform links healthcare stakeholders in the delivery and reimbursement of care, optimizing both business and patient outcomes and providing informed, streamlined diagnostic and business decision-making. To learn more, visit www.xifin.com, or follow XiFin on Twitter at www.twitter.com/#!/XiFin.
Recent Press Releases
-
May 22, 2026
XiFin Applauds House Ways and Means Committee Advancement of the Main Street Pharmacy Access Act
-
May 20, 2026
XiFin Joins Future of Pharmacy Care Coalition to Advance Pharmacist-Delivered Care and Urges Support for ECAPS Legislation
-
Apr 22, 2026
XiFin to Showcase Empower AI and Provide First Look at Appeals Agent at Executive War College
-
Apr 16, 2026
XiFin Introduces Empower AI for Specialty Pharmacy at Asembia AXS26 and Unveils New Specialty Pharmacy Research Findings
-
Apr 8, 2026
XiFin Partners With Premier Radiology Data Intelligence Leaders Science and Medicine Group and AuntMinnie to Launch First-of-Its-Kind Radiology Research Examining Industry Challenges in 2026 and Beyond